Xconomy’s Digital Events →
Dicerna is developing RNA interference drugs.
Sponsored · Whitepaper
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Sponsored · Video
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.